Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05979714 · ClinicalTrials.gov registry record · NA
The Cheeky Study: A Novel Delivery System for CAB-RPV LA
A NA study of HIV Infections, sponsored by Public Health Foundation Enterprises.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05979714: Active NA study of HIV Infections, sponsored by Public Health Foundation Enterprises.
NCT05979714 is a NA study of HIV Infections that is active but no longer recruiting, run by Public Health Foundation Enterprises. The registered enrollment target is 50 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05979714, a NA study of HIV Infections, is active but no longer recruiting, sponsored by Public Health Foundation Enterprises.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-arm implementation study of a novel integrated delivery model of CAB-RPV LA for transwomen living with HIV.
Conditions Studied
Interventions
- OTHER Patient-centered injection site
- BEHAVIORAL Patient-centered adherence support
- OTHER Provider education
- BEHAVIORAL Improved clinic communication strategies
Study Locations (1)
California
- Bridge HIV, San Francisco Department of Public Health - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-31 |
| Est. Completion | 2024-12 |
| Phase | NA |
What the registry record for NCT05979714 still lists
NCT05979714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Patient-centered injection site is the first listed.
NCT05979714 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05979714 about?
NCT05979714 is a clinical study titled "The Cheeky Study: A Novel Delivery System for CAB-RPV LA". This is a single-arm implementation study of a novel integrated delivery model of CAB-RPV LA for transwomen living with HIV.
What is the current status of trial NCT05979714?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-31. Estimated completion is 2024-12.
What conditions does trial NCT05979714 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT05979714?
The interventions under investigation include: Patient-centered injection site (OTHER), Patient-centered adherence support (BEHAVIORAL), Provider education (OTHER), Improved clinic communication strategies (BEHAVIORAL).
Who is sponsoring clinical trial NCT05979714?
This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05979714 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05979714's enrollment target sits among peer trials
50 355th of 542 higher than 177 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI